Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic

Fig. 3

Neutralizing effects of guinea pig antiserum against homologous and heterologous viruses. The property of the guinea pig antisera raised against three types of the clinical viral isolates at a limiting concentration. Oka/2, Sk/23, and Sk/26 were used as representative 144K, 144N, and 45N/144N type viruses, respectively, to obtain neutralizing antibodies. a The neutralizing activity of anti-Oka/2 (144K) antiserum against Oka/2 (144K), Sk/23 (144N) and Sk/26 (45N/144N) viruses. b The neutralizing activity of anti-Sk/23 (144N) antiserum against Oka/2 (144K), Sk/23 (144N) and Sk/26 (45N/144N) viruses. c. The neutralizing activity of anti- Sk/26 (45N/144N) antiserum against Oka/2 (144K), Sk/23 (144N) and Sk/26 (45N/144N) viruses. Results are presented as means ± SD of three independent experiments with duplicate wells

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us